Abiopharma

MiNK Therapeutics and University of Wisconsin–Madison Announce Phase 1 Clinical Trial of Allo-iNKT Cell Therapy (AgenT-797) to Evaluate Prevention of Graft-Versus-Host Disease

New Form SCHEDULE 13G - Ovid Therapeutics Inc. Filed: 2026-01-08 AccNo: 0001623632-26-000052 Size: 45 KB

New Form 5 - CONMED Corp Filed: 2026-01-08 AccNo: 0000816956-26-000002 Size: 5 KB

The Latest from NRC Health | AI and the trust ecosystem, NRC Healths new podcast, and so much more!

Auxly Reviews 2025 Milestones and Provides 2026 Outlook

ALX Oncology to Present at the 44th Annual J.P. Morgan Healthcare Conference

Siokas Grigorios 🟢 acquired 124.9K shares of Cosmos Health Inc. (COSM) at $0.52 Transaction Date: Jan 07, 2026 | Filing ID: 000093

📋 Manley Corey J (Officer) plans to sell 6K shares of OMNICELL, INC. (at $49.90 each, total $305K) Filed: Jan 08, 2026 | ID: 000204

Evotec SE (EVOTF) Files Form 6-K

ENvue Medical to Ring the Nasdaq Opening Bell on Wednesday, January 14th, 2026

Quest Diagnostics to Release Fourth Quarter and Full Year 2025 Financial Results on February 10, 2026

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Mereo BioPharma Group plc - MREO

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Anavex Life Sciences Corp. - AVXL

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Galectin Therapeutics Inc. - GALT

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Organogenesis Holdings Inc. - ORGO